# Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

> **NCT00189371** · PHASE3 · TERMINATED · sponsor: **AGO Study Group** · enrollment: 300 (—)

## Conditions studied

- Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum
- Platinum Sensitve Relapse
- Anemia

## Interventions

- **DRUG:** paclitaxel, carboplatin, epoetin alpha

## Key facts

- **NCT ID:** NCT00189371
- **Lead sponsor:** AGO Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 300 (—)
- **Last updated:** 2005-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189371, "Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00189371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*